This is the second article in the occasional series in which health professionals discuss the contribution of their specialty to quality of patient care.
of Great Britain recommended ways in which community pharmacy should develop in the United Kingdom. 3 Although pharmacists working in hospitals and in the community are committed to ensuring the safe, effective, and economic use of medicines, the activities of the two groups differ in style and emphasis. Two of the key differences are access to the prescriber and degree of Pharmacists have opportunities to discuss disease prevention and health promotion when clients request advice on managing minor ailments. Some pharmacies also display health promotion literature and take part in local initiatives such as advising on immunisation, first and second line treatments for hair infestation, giving up smoking, and needle exchange schemes for intravenous drug misusers.
Privacy is an important aspect of quality of care. If pharmacists are to develop their advisory role, then discussions with clients about their problems with over the counter medicines must clearly take place in a private area set aside for this purpose. The profession is aware of the need for privacy if clients are not to be inhibited from raising their concerns and pharmacists are not to be inhibited from discussing sensitive issues in consultations. Private areas are also useful for discussing prescription drugs with clients. The development of suitable consultation areas is being encouraged and paid for in some family health services authorities.
TEAMWORK
Pharmacists have an important role within the primary health care team. Although they usually work separately from other members of the team, what they do with their clients is a clear extension of the work that starts in the general practitioner's surgery. The relative isolation in which many pharmacists work, and the fact that they work on premises distinct from the rest of the other health professionals, mean that they are sometimes considered to be only on the fringes of the primary health care team. Although pharmacists are required to be on the pharmacy premises during opening hours, there are, nevertheless, many opportunities for meaningful collaboration between them and other primary health care professionals and for regular contact between them, both by telephone and in person.
Community pharmacists share their clients with other practitioners and need to develop these links, not only with prescribers but also with others such as district nurses, health visitors, specialist nurses in the community, physiotherapists, chiropodists, dentists, and occupational therapists. Some pharmacists work with general practitioners on practice formularies, prescribing practices, the interpretation of prescribing analysis and cost (PACT) data, and the review of drugs as part of a home visit. However, there are matters of concern to all health professions -for example, the appropriate use of benzodiazepines, on which communication is currently minimal.20 Both pharmacists and doctors recognise the need to address this problem, to advise clients about appropriate use, to monitor for misuse, and to be prepared to discuss reducing doses when asked. There is growing concern about the participation in issues such as this by members of the two professions, and there is increasing discussion and awareness of the other's activities and contribution to the health of the community. Pharmacists' interventions relate to the whole range of prescribing, many being concerned with the choice of drug, dose, and route of administration. When judging the appropriateness of prescribing other factors also come into play, including the effectiveness of the drug, its cost, and the effect on the quality of life of the patient. Unfortunately, this activity is largely undocumented and unrecognised, and it tends to take place mainly between pharmacists and junior doctors.
In many hospitals at least one pharmacist will attend a consultant's round. 45 Hospital pharmacists also contribute to the economic aspects of drug use -controlling purchasing costs and working with clinicians on formularies, treatment protocols, review and evaluation of drug use, and medical and clinical audit. 4 " At the core of these activities is information from computerized purchasing and dispensing systems and information brought back from the wards by pharmacists. These roles are coming together in the provision of advice to directorates, and clinical directors are increasingly tending to pay their own pharmacists to provide these services.
The future The future of pharmacy is inextricably linked with the future of medicines. The continuing high cost of drugs will ensure the growing importance of pharmacoeconomics. Downward pressures on drug costs will shave the margins of industry and wholesalers, and new technology will change the purchasing and supply stucture. For pharmacy the emphasis will be on a "value added" supply service, with much of the value being in providing information and monitoring quality. Although some of this can be undertaken by computers, there are limitations to this, and there is no substitute for contact with patients. The development of new drugs through biotechnology will lead to difficulties in formulation and administration that will keep pharmacists challenged and involved. The increase in domiciliary care will also make home visits and "closed door" pharmacies common, perhaps leading to competition between hospital and community pharmacists. The effect of market forces on newly established NHS trusts is already forcing reductions in the number of hospital pharmacists, a quarter of senior posts having already gone.5' The danger is that this may lead to a reduced quality of service at some sites. Both purchasers and trusts need to set firm quality standards to ensure that pharmacy services to not become stagnated or atrophied. In community practice the law requiring pharmacists to remain on the premises at all times creates constraints in further developing the role of pharmacists. One possible development is to have more than one pharmacist in each pharmacy so that a wider range of services both inside and outside the pharmacy can be more effectively pursued.
Conclusion
Pharmacists have responded positively to health service changes and to developments in drug treatment. They make a substantial contribution to the overall quality of health care by ensuring that the prescriber's intentions are translated into the safe, effective, and economic use of medicines; that the prescribers themselves have the information necessary to make such decisions; and that patients have the information they need to obtain maximum benefit from their treatment.
Although there are clearly ways in which improvements can be made, the profession of pharmacy can move forward in the knowledge that the benefits of a pharmaceutical service provided by highly educated, motivated, and accessible professional people is well recognised, not only by its clients but also by doctors and by those making policy decisions. It can grasp the many opportunities available to it in the future, including the new roles of the commissioning agencies, with confidence and enthusiasm.
